This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2017 Jun;16(6):413-414.

doi: 10.1016/S1474-4422(17)30127-8.

The neurodegenerative prodrome in multiple sclerosis

Gavin Giovannoni¹

Affiliations

Affiliation

¹ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London E1 2AT, UK. Electronic address: g.giovannoni@qmul.ac.uk.

PMID: 28504102
DOI: 10.1016/S1474-4422(17)30127-8

Comment

The neurodegenerative prodrome in multiple sclerosis

Gavin Giovannoni. Lancet Neurol. 2017 Jun.

. 2017 Jun;16(6):413-414.

doi: 10.1016/S1474-4422(17)30127-8.

Author

Gavin Giovannoni¹

Affiliation

¹ Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University London, London E1 2AT, UK. Electronic address: g.giovannoni@qmul.ac.uk.

PMID: 28504102
DOI: 10.1016/S1474-4422(17)30127-8

No abstract available

PubMed Disclaimer

Comment on

Health-care use before a first demyelinating event suggestive of a multiple sclerosis prodrome: a matched cohort study.
Wijnands JMA, Kingwell E, Zhu F, Zhao Y, Högg T, Stadnyk K, Ekuma O, Lu X, Evans C, Fisk JD, Marrie RA, Tremlett H. Wijnands JMA, et al. Lancet Neurol. 2017 Jun;16(6):445-451. doi: 10.1016/S1474-4422(17)30076-5. Epub 2017 Apr 20. Lancet Neurol. 2017. PMID: 28434855

Publication types

Actions

MeSH terms

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- scite Smart Citations
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information